Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Zoetis Inc (NYSE:ZTS)

62.78
Delayed Data
As of Jun 23
 -0.73 / -1.15%
Today’s Change
45.28
Today|||52-Week Range
63.85
+17.28%
Year-to-Date

Today’s Trading

Previous close63.51
Today’s open63.50
Day’s range62.48 - 63.52
Volume5,215,502
Average volume (3 months)3,303,890
Market cap$30.8B
Dividend yield0.67%
Data as of 4:00pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)+142.65%
Earnings growth (this year)+18.93%
Earnings growth (next 5 years)+14.10%
Revenue growth (last year)+2.58%
P/E ratio36.5
Price/Sales5.46
Price/Book20.81

Competitors

 Today’s
change
Today’s
% change
VRTXVertex Pharmaceutica...-2.03-1.50%
ALXNAlexion Pharmaceutic...-0.16-0.13%
BAXBaxter International...+0.70+1.15%
INCYIncyte Corp+0.65+0.48%
Data as of 4:01pm ET, 06/23/2017

Financials

Next reporting dateAugust 8, 2017
EPS forecast (this quarter)$0.53
Annual revenue (last year)$4.9B
Annual profit (last year)$821.0M
Net profit margin16.80%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Juan Ramón Alaix
Executive Vice President &
President-US Operations
Kristin C. Peck
Corporate headquarters
New Jersey, New Jersey

Forecasts